Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay Luther

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Journal of Clinical and Experimental Hepatology|February 10, 2025
Prevalence and Clinical Correlation of Cardiometabolic Risk Factors in Alcohol-Related Liver Disease and Metabolic Dysfunction and Alcohol Associated Liver Disease (MetALD)Wesley Dixon, Kathleen E Corey, Jay Luther, et al.
Gut Microbes|February 24, 2012
Helicobacter pylori DNA's anti-inflammatory effect on experimental colitisStephanie Y Owyang, Jay Luther, Christopher C Owyang, et al.
Inflammatory Bowel Diseases|August 1, 2015
Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysisManeesh Dave, Kathan Mehta, Jay Luther, et al.
Hepatology Communications|April 27, 2023
Integrated hepatology and addiction care for inpatients with alcohol use disorder improves outcomes: a prospective studyRachael Mahle, Paige McLean Diaz, Chantelle Marshall, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|April 8, 2026
Phosphatidylethanol testing: patterns, demographic and clinical correlates, and outcomesPranay Nadella, William C Oles, Russell P Goodman, et al.
Journal of Crohn'S & Colitis|March 20, 2019
Low-dose Methotrexate has Similar Outcomes to High-dose Methotrexate in Combination with Anti-TNF Therapy in Inflammatory Bowel DiseasesNienke Z Borren, Jay Luther, Francis P Colizzo, et al.
Digestive Diseases and Sciences|June 29, 2018
Long-Term Outcomes of Immunosuppression-Naïve Steroid Responders Following Hospitalization for Ulcerative ColitisAmar Vedamurthy, Louise Xu, Jay Luther, et al.
Inflammatory Bowel Diseases|September 12, 2018
Second-Look Endoscopy in Hospitalized Severe Ulcerative Colitis: A Retrospective Cohort StudyNienke Z Borren, Hamed Khalili, Jay Luther, et al.
The American Journal of Gastroenterology|September 17, 2009
Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerabilityJay Luther, Peter D R Higgins, Phillip S Schoenfeld, et al.
Digestive Diseases and Sciences|January 27, 2018
Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory PathwaysJay Luther, Manish Gala, Suraj J Patel, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Journal of Clinical and Experimental Hepatology|February 10, 2025
Prevalence and Clinical Correlation of Cardiometabolic Risk Factors in Alcohol-Related Liver Disease and Metabolic Dysfunction and Alcohol Associated Liver Disease (MetALD)Wesley Dixon, Kathleen E Corey, Jay Luther, et al.
Gut Microbes|February 24, 2012
Helicobacter pylori DNA's anti-inflammatory effect on experimental colitisStephanie Y Owyang, Jay Luther, Christopher C Owyang, et al.
Inflammatory Bowel Diseases|August 1, 2015
Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysisManeesh Dave, Kathan Mehta, Jay Luther, et al.
Hepatology Communications|April 27, 2023
Integrated hepatology and addiction care for inpatients with alcohol use disorder improves outcomes: a prospective studyRachael Mahle, Paige McLean Diaz, Chantelle Marshall, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|April 8, 2026
Phosphatidylethanol testing: patterns, demographic and clinical correlates, and outcomesPranay Nadella, William C Oles, Russell P Goodman, et al.
Journal of Crohn'S & Colitis|March 20, 2019
Low-dose Methotrexate has Similar Outcomes to High-dose Methotrexate in Combination with Anti-TNF Therapy in Inflammatory Bowel DiseasesNienke Z Borren, Jay Luther, Francis P Colizzo, et al.
Digestive Diseases and Sciences|June 29, 2018
Long-Term Outcomes of Immunosuppression-Naïve Steroid Responders Following Hospitalization for Ulcerative ColitisAmar Vedamurthy, Louise Xu, Jay Luther, et al.
Inflammatory Bowel Diseases|September 12, 2018
Second-Look Endoscopy in Hospitalized Severe Ulcerative Colitis: A Retrospective Cohort StudyNienke Z Borren, Hamed Khalili, Jay Luther, et al.
The American Journal of Gastroenterology|September 17, 2009
Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerabilityJay Luther, Peter D R Higgins, Phillip S Schoenfeld, et al.
Digestive Diseases and Sciences|January 27, 2018
Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory PathwaysJay Luther, Manish Gala, Suraj J Patel, et al.
Pageof 6